Table 4.
Group | G1, ml·dl−1·min−1·100 mmHg−1 | TD, s | Τ, s | MRT, s | r2 |
---|---|---|---|---|---|
SDF | |||||
Control | 19.2 ± 2.4 | 2.3 ± 1.5 | 30.4 ± 7.9 | 32.7 ± 7.4 | 0.80 ± 0.03 |
Drug | 20.5 ± 3.4 | 3.3 ± 1.9 | 31.6 ± 5.3 | 34.9 ± 3.6 | 0.79 ± 0.03 |
l-NMMA | |||||
Control | 12.5 ± 0.8 | 1.0 ± 0.41 | 19.3 ± 4.5 | 20.3 ± 4.5 | 0.73 ± 0.04 |
Drug | 12.4 ± 0.8 | 4.2 ± 3.5 | 35.4 ± 6.8* | 39.6 ± 5.4* | 0.75 ± 0.03 |
SDF + l-NMMA | |||||
Control | 22.9 ± 3.2 | 2.8 ± 2.8 | 43.1 ± 10.3 | 45.9 ± 8.7 | 0.80 ± 0.03 |
Drug | 24.4 ± 8.2 | 5.6 ± 2.8 | 46.5 ± 12.5 | 52.1 ± 10.9 | 0.83 ± 0.04 |
Data are reported as means ± SE.
P < 0.05, control vs. drug.